Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model
Abstract Triple negative breast cancer (TNBC) is known for being very aggressive, heterogeneous and highly metastatic. The standard of care treatment is still chemotherapy, with adjacent toxicity and low efficacy, highlighting the need for alternative and more effective therapeutic strategies. Edelf...
Guardado en:
Autores principales: | Sofia M. Saraiva, Carlha Gutiérrez-Lovera, Jeannette Martínez-Val, Sainza Lores, Belén L. Bouzo, Sandra Díez-Villares, Sandra Alijas, Alba Pensado-López, Abi Judit Vázquez-Ríos, Laura Sánchez, María de la Fuente |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c5de57641ca74482844ef4a0299e782b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer
por: Belén L. Bouzo, et al.
Publicado: (2021) -
Biodistribution of 68/67Ga-Radiolabeled Sphingolipid Nanoemulsions by PET and SPECT Imaging
por: Díez-Villares S, et al.
Publicado: (2021) -
Targeted therapy of human leukemia xenografts in immunodeficient zebrafish
por: Ranganatha R. Somasagara, et al.
Publicado: (2021) -
Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts
por: Miguel Martin, et al.
Publicado: (2021) -
Innate immune evasion revealed in a colorectal zebrafish xenograft model
por: Vanda Póvoa, et al.
Publicado: (2021)